Elsevier

Microbial Pathogenesis

Volume 148, November 2020, 104484
Microbial Pathogenesis

Immune response in COVID-19: What do we currently know?

https://doi.org/10.1016/j.micpath.2020.104484Get rights and content

Highlights

  • SARS-CoV-2 versus SARS-CoV immune response.

  • Clinical features of COVID-19.

  • Immune response in SARS-CoV and SARS-CoV-2 infection.

  • Immune Memory in coronavirus infection.

Abstract

In 2002/2003 there was a pandemic denominate SARS (severe acute respiratory syndrome), caused by the SARS-CoV virus that belongs to the genera Betacoranavirus and the family Coronaviridae, generally responsible for influenza infections. In mid of 2019, a new disease by the coronavirus named by COVID-19 (SARS-CoV-2) emerged, both infections have flu symptoms, however they are infections that variable intensity, being medium to severe. In medium infections individuals have the virus and exhibit symptoms, however hospitalization is not necessary, in severe infections, individuals are hospitalized, have high pathology and in some cases progress to death. The virus is formed by simple positive RNA, enveloped, non-segmented, and presenting the largest genome of viruses constituting 32 Kb, consisting of envelope proteins, membrane, nucleocapsid and spike protein, which is essential in the interaction with the host cells. As for the origin of this virus, research has been intensified to determine this paradox and although the similarity with SARS-CoV, this virus did not has necessarily the same place of origin. As for the immune system, it is currently unknown how this new virus interacts. In this brief review, we demonstrate important considerations about the responses to this infection.

Cited by (0)

View Abstract